Akela Pharma plans IPO
Read full story for latest details......»»
Zosano Pharma confirms plans to proceed with PK study after FDA protocol review
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Why Mustang Bio, Phathom Pharma And More Are Moving Today
Mustang Bio (NASDAQ: MBIO) shares are trading higher after the company announced the FDA has lifted the clinical hold for its pivotal phase 2 MB-107 clinical trial. The company plans to enroll the first patient in the second quarter of 2021. read more.....»»
Albireo Pharma plans to initiate trial in biliary atresia in 1H20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Dispensed: Big Pharma"s plans to compete with buzzy startups, Sanofi"s entrance to the coronavirus vaccine race, and a Medicare Advantage pitch deck
Courtesy Rx Clinic Pharmac.....»»
Pharma giant Eli Lilly and Company taps Durham for 450+ jobs
Eli Lilly and Company plans to bring more than 462 jobs to a new Durham County facility. The drug giant picked Durham County for a $474 million investment over competing sites in both Indiana and Pennsylvania. The announcement was made Tuesday. E.....»»
Astellas bets $3 billion in gene therapy deal
Shares of Astellas Pharma Inc. rose about 1% in premarket trading after the Japanese drugmaker said Monday evening that it plans to acquire Audentes.....»»
Triangle drugmaker plans merger with Israeli pharma
The merger of a Triangle public drugmaker and an Israeli outfit led by former-Salix executives could have huge potential for Raleigh and its gastrointestinal candidates......»»
Oyster Point Pharma looks to raise up to $85 million in IPO
Oyster Point Pharma Inc. said late Friday it plans to launch an initial public offering, according to a filing w.....»»
Plans for a biotech, pharma hub stall in Elk Grove
Plans to open a new biotech and pharmaceutical hub in Elk Grove have interest. It's finding space that's the hard part......»»
Regeneron plans $800M NY production push, workforce growth, Fierce Pharma says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pharma-owned plasma center set for major expansion in metro Phoenix
Plans call for opening four centers this year that would employ 140 people in the region......»»
Englewood pharma company announces public offering of stock
The company plans to offer up to $12 million of its stock......»»
California"s Kite Pharma plans to hire hundreds at new Frederick facility
Los Angeles biopharmaceutical company Kite Pharma plans to open a new manufacturing facility in Frederick County that will produce cell therapies for people with cancer. The company, a subsidiary of Gilead Sciences (NASDAQ: GILD), will build its.....»»
Pharma distributors jump after Amazon reportedly shelves drug selling plans
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Your Daily Pharma Scoop: Omeros Up On Update, Synergy Sales, President"s Healthcare Plans
Your Daily Pharma Scoop: Omeros Up On Update, Synergy Sales, President"s Healthcare Plans.....»»
Breakingviews TV - Trump drug dump
The president has unveiled long-promised plans to bring down the price of prescription medication. Antony Currie and Robert Cyran explain how it’s far more of a sop to the pharma industry than a salve for overcharged consumers......»»
Flex Pharma Down on Workforce Reduction, Ends Phase II Study
Flex Pharma (FLKS) announced that the company is ending the phase II studies for its pipeline candidate FLX-787 in two indications. The company also plans to lower its workforce by about 60%. F.....»»
Perrigo plans to separate prescription pharma business
Perrigo Co Plc said on Thursday it would separate its generics prescription business, which has been a drag on results, to focus on consumer healthcare following a strategic review, sending the drugmaker's shares down about 8 percent......»»
Medical-marijuana company GW Pharma to sell $300 million in stock offering
GW Pharmaceuticals PLC said late Monday that it plans to sell $300 million worth of American depositary shares. Shares in the company fell 1.6% after hours. GW is a U.K.-based pharmaceutical company that.....»»
Goldman Sachs Takes Action on Pharma Stocks
WellCare Health Plans and Regeneron Pharmaceuticals are on the conviction buy listRelated Stocks: WCG, CTMX, REGN, UHS, GS,.....»»